BUTTURINI, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 3.866
NA - Nord America 3.670
AS - Asia 1.443
AF - Africa 16
OC - Oceania 10
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 9.020
Nazione #
US - Stati Uniti d'America 3.660
GB - Regno Unito 1.786
CN - Cina 1.119
SE - Svezia 368
IT - Italia 343
IE - Irlanda 299
FR - Francia 258
DE - Germania 252
RU - Federazione Russa 212
FI - Finlandia 199
SG - Singapore 189
UA - Ucraina 69
JP - Giappone 42
TR - Turchia 22
BE - Belgio 21
IR - Iran 18
KR - Corea 14
TG - Togo 12
NL - Olanda 11
VN - Vietnam 11
CZ - Repubblica Ceca 10
AT - Austria 9
CA - Canada 9
AU - Australia 7
IN - India 7
BR - Brasile 5
LV - Lettonia 5
EU - Europa 4
AE - Emirati Arabi Uniti 3
ES - Italia 3
GR - Grecia 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
CL - Cile 2
HU - Ungheria 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MK - Macedonia 2
NO - Norvegia 2
PH - Filippine 2
PK - Pakistan 2
RO - Romania 2
RS - Serbia 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BD - Bangladesh 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
ID - Indonesia 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
LU - Lussemburgo 1
MY - Malesia 1
PE - Perù 1
PL - Polonia 1
SI - Slovenia 1
TW - Taiwan 1
Totale 9.020
Città #
Southend 1.670
Chandler 736
Woodbridge 525
Jacksonville 472
Dublin 296
Ann Arbor 285
Ashburn 196
Houston 194
Beijing 153
Jinan 141
Singapore 134
Lawrence 105
Princeton 105
Wilmington 102
Verona 88
New York 81
Nanjing 80
Shenyang 80
Hebei 59
Helsinki 53
Lancaster 51
Tianjin 48
Haikou 45
Nanchang 40
Sindelfingen 39
Hangzhou 38
Zhengzhou 36
Taiyuan 32
Tokyo 32
Ningbo 31
Bologna 29
Fairfield 27
Changsha 26
Taizhou 25
Brussels 21
Falls Church 20
Guangzhou 20
Jiaxing 20
Milan 20
Norwalk 19
Kent 18
Seattle 17
Washington 17
Boardman 16
Dallas 16
Düsseldorf 15
Fuzhou 15
Redwood City 15
Redmond 14
Rome 14
Seoul 14
Lanzhou 12
Lomé 12
Vicenza 12
San Francisco 11
Dearborn 10
Los Angeles 10
Toronto 9
Genova 8
Santa Clara 8
Lappeenranta 7
Sacramento 7
Brno 6
Dong Ket 6
Romola 6
Trento 6
Zanjan 6
Foresto 5
Kyoto 5
San Mateo 5
Treviso 5
Auburn Hills 4
Clearwater 4
Frankfurt am Main 4
Grafing 4
Minoh 4
Porto Mantovano 4
San Diego 4
Vienna 4
Borgo Valsugana 3
Bronx 3
Canberra 3
Chions 3
Detroit 3
Genazzano 3
London 3
Sydney 3
São Paulo 3
Trieste 3
Amsterdam 2
Auckland 2
Boretto 2
Castel San Giorgio 2
Chaoyang 2
Davao City 2
Dongguan 2
Edinburgh 2
Huntington 2
Jeffries 2
Kemerovo 2
Totale 6.585
Nome #
Whole-genome landscape of pancreatic neuroendocrine tumours 163
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 152
Tumor-like lesionsof the pancreas. 140
Laparoscopic distal pancreatectomy: results on a consecutive series of 58 patients. 136
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. 136
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 127
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 117
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 116
Role of unlabelled somatostatin analogues in the prevention of complications after elective pancreatic and peripancreatic surgery: a critical review 115
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 114
Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. 113
Perfusion Changes in Liver Metastases (LM) from Pancreatic Neuroendocrine Tumors (PanNETs) during Everolimus (E) Treatment: Update of Perfusion CT (P-CT) Study 109
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 107
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 107
Enucleation of pancreatic neoplasms. 105
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 105
Role of Combined Ga-68-DOTATOC and F-18-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors Implications for Managing Surgical Decisions 105
Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results 103
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 103
Postoperative pancreatic fistula: an international study group (ISGPF) definition 102
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 102
Pancreatic fistola rate after pancreatic resection. The importance of definition. 99
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 99
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage 99
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma. 98
Open pancreaticogastrostomy after pancreaticoduodenectomy: a pilot study. 98
Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma. 98
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 98
Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients. 97
Open pancreaticogastrostomy after pancreaticoduodenectomy: a pilot study 96
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 96
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 95
Pancreaticojejunostomy after pancreaticoduodenectomy: Suture material and incidence of post-operative pancreatic fistula 95
The role of laparoscopy in advanced pancreatic cancer diagnosis. 94
Outcome of open necrosectomy in acute pancreatitis. 94
A root-cause analysis of mortality following major pancreatectomy 94
Duct-to-mucosa versus end-to-side pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: Results of a prospective randomized trial 92
High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma. 92
ESGAR 2016 Book of Abstracts 92
Value of regional lymphadenectomy in pancreatic cancer. 91
Anastomotic leakage in pancreatic surgery. 90
Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes 90
To what extent is surgery superior to endoscopic therapy in the management of chronic pancreatitis? 89
Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma 89
Anastomotic leakeage in pancreatic surgery 88
Anastomotic leakage in pancreatic surgery. 88
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 88
The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 15-3. 87
Anastomotic leakage in pancreatic surgery. 87
Minimally invasive pancreatic surgery - a review 87
Pan-European survey on the implementation of minimally invasive pancreatic surgery with emphasis on cancer 87
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 87
Intravoxel incoherent motion diffusion-weighted MR imaging of solid pancreatic masses: reliability and usefulness for characterization 87
Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer 85
Pancreatoblastoma in adults: a review of the literature. 85
Digital Subtraction of Magnetic Resonance Images Improves Detection and Characterization of Pancreatic Neuroendocrine Neoplasms 84
Enucleation of pancreatic neoplasms 83
Symptoms and Quality of Life in Chronic Pancreatitis Assessed by Structured Interview and the EORTC QLQ-C30 and QLQ-PAN26 82
Pancreatic fistula: definition and current problems. 81
Non-hyperfunctioning neuroendocrine tumours of the pancreas: MR imaging appearance and correlation with their biological behaviour 81
Surveillance for Pancreatic Cancer in High-Risk Individuals: First-Round Screening Results of a Multicentric Italian Program 81
Laparoscopic pancreatectomy for solid pseudo-papillary tumors of the pancreas is a suitable technique; our experience with long-term follow-up and review of the literature 81
Pancreatectomy with Para-Aortic Lymph Node Dissection for Pancreatic Head Adenocarcinoma: Pattern of Nodal Metastasis Spread and Analysis of Prognostic Factors 80
Pancreatic ductal adenocarcinoma can be detected by analysis of volatile organic compounds (VOCs) in alveolar air 79
Lymph nodes metastasis and recurrences justify an aggressive treatment of gastrinoma. 78
Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology 77
Management of functioning endocrine pancreatic tumors. 76
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling 76
Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. 76
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula - Results of a prospective study in 137 patients 75
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors 75
Surgical strategy in the treatment of pancreatic neuroendocrine tumors. 75
Streptozotocin/5-Fluorouracil (STZ/5FU) Chemotherapy in G1-G2 Pancreatic Neuroendocrine Tumors (pNETs): Single Institution Experience 73
Perioperative and long-term results of laparoscopic spleen-preserving distal pancreatectomy with or without splenic vessels conservation: A retrospective analysis 72
Histogram analysis of ADC maps: assessment of intra-tumoral heterogeneity and correlation with the biological behavior of pancreatic neuroendocrine neoplasms 71
Uncommon presentations of common pancreatic neoplasms: a pictorial essay 70
Evaluation of UICC TNM classification for pancreatic cancer. A study of 228 patients 69
Different Ideas of Nodal Grouping in Standard and Extended Lymphadenectomy During Pancreaticoduodenectomy for Pancreatic Head Cancer 69
Perioperative management of patients undergoing pancreatic resection: implementation of a care plan in a tertiary-care center. 69
Drain Management after Pancreatoduodenectomy: Reappraisal of a Prospective Randomized Trial Using Risk Stratification 69
Pancreaticoduodenectomy with harmonic focust curved shears for cancer 68
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 68
Poor Results of Pancreatoduodenectomy in High-Risk Patients with Endoscopic Stent and Bile Colonization are Associated with E. coli, Diabetes and Advanced Age 67
Minimally Invasive Surgery for Pancreatic Neuroendocrine Tumors: Why Not? 66
Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study 65
Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group 65
Long term outcome after minimally invasive and open Warshaw and Kimura techniques for spleen-preserving distal pancreatectomy: International multicenter retrospective study 64
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma. 63
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 63
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 63
Surgical strategy in the treatment of pancreatic neuroendocrine tumors 62
Results of First-round of Surveillance in Individuals at High-risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry 62
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment 62
Growth pattern of serous cystic neoplasms of the pancreas: observational study with long-term magnetic resonance surveillance and recommendations for treatment 61
Magnetic resonance (MR) for mural nodule detection studying Intraductal papillary mucinous neoplasms (IPMN) of pancreas: Imaging-pathologic correlation 59
Normal Tissue Perfusion Changes During Everolimus Treatment: Preliminary Results from a Functional Vascular Study 58
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients 58
Residual pancreatic function after pancreaticoduodenectomy is better preserved with pancreaticojejunostomy than pancreaticogastrostomy: A long-term analysis 54
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA) 53
Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. 51
Totale 8.742
Categoria #
all - tutte 31.133
article - articoli 28.585
book - libri 0
conference - conferenze 2.219
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 329
Totale 62.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020750 0 0 0 51 121 110 122 60 40 70 61 115
2020/20211.066 117 173 56 247 116 89 32 43 59 20 81 33
2021/2022847 68 229 10 45 49 42 20 42 29 23 85 205
2022/20232.001 134 230 185 357 158 471 25 131 224 16 44 26
2023/20241.002 34 73 97 120 130 175 59 62 6 41 164 41
2024/2025469 132 135 99 103 0 0 0 0 0 0 0 0
Totale 9.159